People · Operator
Named in public records as an officer, director or promoter · active 2011–2022 · Pharma, Biotechnology, Other Health Care, Pharmaceuticals, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bright Peak Therapeutics, Inc. | — | Pharma | Series D+ | $196.5M | $1.0B | 2021 |
| Ventus Therapeutics U.S., Inc. | — | Biotechnology | Series C | $186.8M | $1.6B | 2021 |
| PepGen Inc. | — | Biotechnology | Series D+ | $126.9M | $3.2B | 2020 |
| Iscience Interventional Corp | — | Other Health Care | Series B | $40.3M | $61.1M | 2011 |
| CoStim Pharmaceuticals Inc. | — | Pharmaceuticals | Series A | $10.0M | $309.9M | 2013 |
| Limber, Inc. | — | Other | Seed | $2.2M | $41.4M | 2019 |
| nProgress, Inc. | — | Other Technology | Seed | $1.8M | $60.9M | 2011 |
Josh Resnick at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Josh Resnick on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Asish Xavier | 2 | 18 |
| Jean-Francois Formela | 1 | 17 |
| Jerel Davis | 1 | 13 |
| Joshua Resnick | 1 | 12 |
| Luke Evnin | 1 | 12 |
| BUZZ BENSON | 1 | 8 |
| TING PAU OEI | 1 | 7 |
| Scott Ward | 1 | 7 |
| Laura Shawver | 1 | 6 |
| HEIDI HENSON | 1 | 5 |
| Joseph Mandato | 1 | 5 |
| Matthew Wood | 1 | 5 |
| Hao Wu | 1 | 5 |
| Roger Kitterman | 1 | 5 |
| Alexander Mayweg | 1 | 4 |
| Kazumi Shiosaki | 1 | 4 |
| Wilfred Jaeger | 1 | 4 |
| Marian Nakada | 1 | 4 |
| Frederick Dotzler | 1 | 3 |
| Jarl Mohn | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.